Masimo expects full-year earnings in the range of $2.80 to ... using data from Zacks Investment Research. Access a Zacks stock report on MASI at https://www.zacks.com/ap/MASI
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company's business is Measure-through Motion and Low Perfusion pulse …
Massimo Zanetti Beverage Group SpA (MZB Group) is an Italy-based holding company engaged in the food processing industry. The Company mainly focuses on the production of coffee. Massimo Zanetti Beverage Group SpA controls the …
10 stocks we like better than Masimo When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.* …
About a month has gone by since the last earnings report for Masimo Corporation MASI. Shares have lost about 1.5% in that time frame, underperforming the market. Will the recent negative trend continue leading up to the stock's next …
Masimo Corporation (NASDAQ: MASI), a mid-cap medical technology company, reported stronger-than-expected second-quarter results after the bell Wednesday, but investors still decided to hit the exits en mass Thursday. Specifically, the …
For FY17, Masimo is estimating earnings per diluted share to be approximately $2.95, up from the earlier guidance of $2.80 per diluted share. Stock Performance Snapshot December 07, 2017 - At Thursday's closing bell, Masimo's stock …